Voprosy Virusologii

Aims & Scope

International peer-reviewed scientific and practical journal “Problems of Virology” (Russian title “Voprosy virusologii”, ISSN (Print) 0507-4088, ISSN (Online) 2411-2097) acquaints readers with the achievements of Russian and international virology, publishes articles on the study of viruses and viral diseases of humans, animals and plants.

A prominent place in the journal is given to the publication of the results of experimental studies on various fields in fundamental and applied virology.

The journal publishes materials that contribute to the implementation in practice of the achievements of virological science in eliminating and reducing the prevalence of infectious diseases, as well as its diagnosis, prevention and treatment.

The review articles summarize the latest advances in virology.

In order to attract the attention of virologists to the most actual issues requiring further study, the journal publishes editorial notes and book reviews.

The reader will find in the journal a description of new research methods, new equipment, diagnostic and treatment tools.

The journal is intended for virologists (medical and veterinary), epidemiologists, parasitologists, pharmacologists, biochemists and other specialists.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Medline
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Immunology and Microbiology and Medicine, ensuring accessibility and quality in research dissemination.

This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Etiology of epidemic outbreaks COVID-19 in Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (<i>Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus</i>, Subgenus <i>Sarbecovirus</i>): lessons of SARS-CoV outbreak

  Citation: 49

  Authors: D. K., S. V., L. V., E. I.

• Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus)

  Citation: 45

  Authors: Dmitry K., Sergey V.

• Monitoring the spread of the SARS-CoV-2 (Coronaviridae: Coronavirinae: Betacoronavirus; Sarbecovirus) variants in the Moscow region using targeted high-throughput sequencing

  Citation: 31

  Authors: N. I., I. A., A. A., V. V., A. S., L. Yu., E. V., K. F., V. G.

• Reactivation of Epstein–Barr virus (<i>Herpesviridae: Lymphocryptovirus</i>, HHV-4) infection during COVID-19: epidemiological features

  Citation: 27

  Authors: T. V., T. A., N. N., S. L., V. F., D. I., A. V., E. B.

• Patterns of the SARS-CoV-2 epidemic spread in a megacity

  Citation: 23

  Authors: V. G., S. N., T. A., O. Yu., S. B., E. V., A. V., I. V., M. A., O. A., A. A., M. V., M. A., V. V., E. E., A. V.

• Interferon gamma in the treatment of patients with moderate COVID-19

  Citation: 23

  Authors: A. L., S. A., P. A., F. I.

• Peculiarities of the influenza and ARVI viruses circulation during epidemic season 2019–2020 in some regions of Russia

  Citation: 22

  Authors: D. K., E. I., L. V., I. T., N. V., A. V., K. G., E. L., S. V., N. V., L. N., E. A., I. N., O. L., E. I., M. S., N. N., R. V., L. B., I. M., E. S., A. G., I. S., A. L., M. V., S. V., M. V., N. L., A. V.

• The role of Epstein-Barr viral infection and hepatitis B and C in liver pathology

  Citation: 22

  Authors: T. V., T. A., M. Yu.

• Viral hepatitis B, C and infectious mononucleosis: epidemiological similarities and differences

  Citation: 18

  Authors: T. V., T. A.

• Lethal cases of lyssavirus encephalitis in humans after contact with bats in the Russian Far East in 2019–2021

  Citation: 17

  Authors: E. M., D. N., G. N., T. S., N. S., A. Zh.